CGEM - Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga
CAMBRIDGE, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (NASDAQ:CGEM) ("Cullinan Oncology") a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today announced that Chief Executive Officer, Nadim Ahmed, will present at the 42nd Annual J.P. Morgan Healthcare Conference, being held January 8-11, 2024 in San Francisco, CA. Mr. Ahmed's presentation is scheduled for Thursday, January 11, at 10:30 am PST (1:30 pm EST).
A live webcast of the presentation will be available via the Events and Presentations section of the Company's investor relations website at https://cullinanoncology.com/events-and-presentations/.
About Cullinan Oncology